Pleckstrin-2 (PLEK2)

Pleckstrin-2 (PLEK2) is an intracellular signal transduction protein characterized by two pleckstrin homology (PH) domains and a central DEP domain, which mediate its association with phosphatidylinositols generated downstream of PI3K signaling. PLEK2 facilitates reorganization of the actin cytoskeleton, promoting cell spreading, migration, and membrane protrusion dynamics, and is essential for enucleation during erythropoiesis. It is widely expressed in multiple tissues and is upregulated in several malignancies, where it enhances epithelial-mesenchymal transition, metastasis, vascular invasion, and cell cycle progression. In immune cells, PLEK2 regulates cytoskeletal rearrangement and immune synapse formation. Its known interaction partners include actin, Rac GTPases, phosphatidylinositols, SHIP2 (regulating lung cancer metastasis), and EGFR (involved in gallbladder cancer EMT). Loss of pleckstrin-2 impairs erythropoiesis, increases apoptosis, and may result in anemia and embryonic lethality in animal models, indicating its critical role in development and cell integrity[1][2][3].

Other names

Pleckstrin-2PLEK2pleckstrin-2pleckstrin 2 homolog

Hypothetical and investigative drugs would target pleckstrin-2 to inhibit tumorigenesis, metastasis, or erythroid defects by modulating its interactions with PI3K-phosphorylated phospholipids or its regulatory activity over actin dynamics. Mechanisms for such drugs could include inhibiting PLEK2’s phospholipid binding, blocking interaction with actin or Rac GTPases, or destabilizing membrane localization.